We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WDR
401
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $3.69M | 0.05% |
221,308
+51,730
| +31% | +$902K |
|
402
UnitedHealth
UNH
$382B
| $3.69M | 0.05% |
15,111
-4,211
| -22% | -$1.01M |
|
403
Heritage Insurance Holdings
HRTG
$842M
| $3.68M | 0.05% |
238,933
+37,590
| +19% | +$553K |
|
|
CKH
404
DELISTED
Seacor Holdings Inc.
CKH
| $3.68M | 0.05% |
77,467
-35,450
| -31% | -$1.56M |
|
405
Scansource
SCSC
$1.12B
| $3.66M | 0.05% |
112,299
+11,980
| +12% | +$407K |
|
406
Workday
WDAY
$33.4B
| $3.63M | 0.05% |
17,650
-1,010
| -5% | -$204K |
|
407
Chesapeake Utilities
CPK
$3.26B
| $3.6M | 0.05% |
37,941
+8,027
| +27% | +$744K |
|
|
EPAY
408
DELISTED
Bottomline Technologies Inc
EPAY
| $3.58M | 0.05% |
81,040
+13,140
| +19% | +$610K |
|
|
BMCH
409
DELISTED
BMC Stock Holdings, Inc
BMCH
| $3.58M | 0.05% |
168,709
+88,632
| +111% | +$1.84M |
|
|
CLDT
410
Chatham Lodging
CLDT
$630M
| $3.56M | 0.05% |
188,488
+36,370
| +24% | +$712K |
|
|
MNK
411
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $3.53M | 0.05% |
384,593
-130,597
| -25% | -$1.89M |
|
|
FBM
412
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $3.51M | 0.05% |
197,234
+23,150
| +13% | +$333K |
|
|
SPLK
413
DELISTED
Splunk Inc
SPLK
| $3.48M | 0.05% |
27,650
-90,560
| -77% | -$11.5M |
|
|
EVRI
414
DELISTED
Everi Holdings
EVRI
| $3.43M | 0.05% |
287,353
-90,392
| -24% | -$981K |
|
|
TBRG
415
DELISTED
TruBridge
TBRG
| $3.42M | 0.05% |
123,097
+37,128
| +43% | +$1.04M |
|
416
Monolithic Power Systems
MPWR
$65.5B
| $3.41M | 0.05% |
+25,130
| New | +$3.42M |
|
417
WaFd
WAFD
$2.72B
| $3.41M | 0.05% |
97,566
+31,730
| +48% | +$1.03M |
|
418
CVR Energy
CVI
$3.36B
| $3.41M | 0.05% |
68,146
-530
| -0.8% | -$23.8K |
|
419
Chemours
CC
$2.59B
| $3.39M | 0.05% |
141,324
-51,610
| -27% | -$1.52M |
|
|
DBD
420
DELISTED
Diebold Nixdorf Incorporated
DBD
| $3.38M | 0.05% |
369,294
-76,180
| -17% | -$795K |
|
|
OPB
421
DELISTED
Opus Bank Common Stock
OPB
| $3.37M | 0.05% |
159,418
+30,976
| +24% | +$653K |
|
422
Magnite
MGNI
$2.65B
| $3.34M | 0.05% |
525,859
+248,413
| +90% | +$1.53M |
|
|
IBKC
423
DELISTED
IBERIABANK Corp
IBKC
| $3.34M | 0.05% |
44,058
+11,700
| +36% | +$889K |
|
|
ACBI
424
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $3.34M | 0.05% |
195,013
+11,250
| +6% | +$196K |
|
|
AKRX
425
DELISTED
Akorn Inc
AKRX
| $3.31M | 0.05% |
642,902
+65,120
| +11% | +$251K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.